Increase/Decrease in Cash: The total change in cash for the company over the given period.
Belite Bio, Inc. Sponsored ADR (BLTE) had Increase/Decrease in Cash of $321.25M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-77.61M |
|
-- |
|
-- |
|
$84.21M |
|
$-84.21M |
|
$6.60M |
|
$-77.61M |
|
$-77.61M |
|
$-77.61M |
|
$-77.61M |
|
$-77.61M |
|
$-77.61M |
|
$-84.21M |
|
$-83.74M |
|
33.54M |
|
33.54M |
|
$-2.31 |
|
$-2.31 |
|
| Balance Sheet Financials | |
$494.27M |
|
$0.34M |
|
$286.28M |
|
$780.56M |
|
$9.88M |
|
-- |
|
$0.19M |
|
$10.07M |
|
$770.49M |
|
$770.47M |
|
$770.49M |
|
39.34M |
|
| Cash Flow Statement Financials | |
$-36.99M |
|
$-305.11M |
|
$663.23M |
|
$31.68M |
|
$352.93M |
|
|
Increase/Decrease in Cash |
$321.25M |
$38.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
50.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.07% |
|
-10.07% |
|
-9.94% |
|
-10.07% |
|
$19.59 |
|
$-1.11 |
|
$-1.10 |
|